Zymeworks ZYME Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$81.13M+33.9% | -$122.7M-3.4% | -$118.67M-195% | $124.34M+159% | ||
| $3.67M-12.4% | $4.19M-43.9% | $7.46M+20.0% | $6.22M+66.4% | ||
| $28.03M+57.6% | $17.79M+120% | $8.1M— | —— | ||
| -$945K-36.8% | -$691K-191% | $757K— | —— | ||
| —— | —— | —— | —— | ||
| —— | —— | -$13.92M-180% | $17.51M— | ||
| —— | —— | —— | $26.48M— | ||
| —— | —— | —— | —— | ||
| -$23.17M— | —— | —— | —— | ||
| -$45K+97.3% | -$1.68M-273% | $970K— | —— | ||
| $4.06M-9.8% | $4.5M+66.4% | $2.7M+166% | $1.02M— | ||
| $3.39M+34.9% | $2.51M-64.9% | $7.14M+49.7% | $4.77M— | ||
| -$33.01M+70.0% | -$110.06M— | —— | $144.11M— | ||
| $1.52M-23.6% | $1.99M-19.5% | $2.47M-69.6% | $8.15M— | ||
| $831K-22.7% | $1.08M-32.9% | $1.6M-67.8% | $4.98M— | ||
| $26.66M— | —— | -$207.25M-285% | -$53.85M-137% | ||
| —— | —— | —— | $0— | ||
| $0— | $0— | —— | —— | ||
| -$18.56M+9.2% | -$20.44M-125% | $81.87M— | —— | ||
| —— | $294K— | —— | —— | ||
| -$24.95M— | —— | —— | $199.05M— | ||
| $1.35M-57.5% | $3.18M+1,827% | $165K-98.4% | $10M— | ||
| —— | —— | —— | —— | ||
| $4.06M-9.8% | $4.5M+66.4% | $2.7M+166% | $1.02M— | ||
| $3.67M-12.4% | $4.19M-43.9% | $7.46M+20.0% | $6.22M+66.4% | ||
| —— | $1.62M— | —— | —— | ||
| -$945K-36.8% | -$691K-191% | $757K— | —— | ||
| -$3.34M+59.8% | -$8.31M-127% | -$3.66M+2.0% | -$3.74M— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $3.39M+34.9% | $2.51M-64.9% | $7.14M+49.7% | $4.77M— | ||
| $831K-22.7% | $1.08M-32.9% | $1.6M-67.8% | $4.98M— | ||
| —— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| $16.9M+90.9% | $8.86M+76.9% | $5.01M+1,863% | $255K— | ||
| —— | —— | —— | —— | ||
| $2.44M+279% | $644K-66.1% | $1.9M— | —— | ||
| $1.35M-57.5% | $3.18M+1,827% | $165K-98.4% | $10M— | ||
| -$34.53M+69.2% | -$112.05M— | —— | $135.96M— | ||
| -$34.53M+69.2% | -$112.05M— | —— | $135.96M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Zymeworks generate?
- Zymeworks (ZYME) generated -$75.3M in operating cash flow over the trailing twelve months.
- What is Zymeworks's free cash flow?
- After $1.7M of capital expenditures, Zymeworks's free cash flow was -$77.0M over the trailing twelve months, up 0.7% year over year.
- Where does Zymeworks's cash flow data come from?
- Every line is extracted from Zymeworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
